3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

• Published in: Blood Vol. 142; no. Supplement 1; p. 3165
• Main Authors: Malagola, Michele, Iurlo, Alessandra, Bucelli, Cristina, Abruzzese, Elisabetta, Bonifacio, Massimiliano, Stagno, Fabio, Binotto, Gianni, D'Adda, Mariella, Lunghi, Monia, Crugnola, Monica, Ferrari, Maria Luisa, Lunghi, Francesca, Castagnetti, Fausto, Rosti, Gianantonio, Lemoli, Roberto Massimo, Sancetta, Rosaria, Coppi, Maria Rosaria, Corsetti, Maria Teresa, Dalmazzo, Matteo, Romano, Atelda, Tiribelli, Mario, Russo Rossi, Antonella, Russo, Sabina, Sicuranza, Anna, Roccaro, Aldo, Butturini, Giulia, Farina, Mirko, Bernardi, Simona, Pellizzeri, Simone, Polverelli, Nicola, Russo, Domenico
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 02.11.2023

The goal of Treatment Free Remission (TFR) is achievable in no more than 25-30% of patients with Ph+ Chronic Myeloid Leukemia (CML) treated with Tyrosine Kinase Inhibitors (TKIs). Thus, for the great majority of patients, particularly for the elderly, the options are to continue TKI therapy life-lon...